What This Means for Healthcare Providers The popularity of GLP-1 medications has led to a surge in online marketing for compounded or research versions of drugs that have not yet received FDA approval
Risk stratification to improve care and outcomes in diabetic kidney disease
BAS/1/1624-01-01, FCC/1/1976-20-01, FCC/1/1976-26-01, and Contract No#OSR 4129
The key question now is whether this strategy holds up in larger, controlled studies
Lets start with those that primarily involve one type of amino acid, vitamin, peptide, or essential compound
1 The discovery of GLP-1 The journey began with Habener and Mojsovs identification of the physiological roles of GLP-1, a hormone initially discovered as an incretin, which is released by the gut (Drucker et al 1986) (Fig